George Yancopoulos - May 16, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Stock symbol
REGN
Transactions as of
May 16, 2024
Transactions value $
-$48,636,545
Form type
4
Date filed
5/17/2024, 04:06 PM
Previous filing
May 17, 2024
Next filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$877K -907 -0.11% $967.40 835K May 16, 2024 Direct F1, F2
transaction REGN Common Stock Sale -$3.11M -3.21K -0.38% $968.44 832K May 16, 2024 Direct F1, F3
transaction REGN Common Stock Sale -$9.21M -9.5K -1.14% $969.39 823K May 16, 2024 Direct F1, F4
transaction REGN Common Stock Sale -$4.53M -4.67K -0.57% $970.26 818K May 16, 2024 Direct F1, F5
transaction REGN Common Stock Sale -$4.78M -4.92K -0.6% $971.56 813K May 16, 2024 Direct F1, F6
transaction REGN Common Stock Sale -$768K -790 -0.1% $972.22 812K May 16, 2024 Direct F1, F7
transaction REGN Common Stock Sale -$2.58M -2.65K -0.33% $973.80 810K May 16, 2024 Direct F1, F8
transaction REGN Common Stock Sale -$7.42M -7.61K -0.94% $974.51 802K May 16, 2024 Direct F1, F9
transaction REGN Common Stock Sale -$9.02M -9.24K -1.15% $975.48 793K May 16, 2024 Direct F1, F10
transaction REGN Common Stock Sale -$4.77M -4.89K -0.62% $976.52 788K May 16, 2024 Direct F1, F11
transaction REGN Common Stock Sale -$1.2M -1.23K -0.16% $977.38 787K May 16, 2024 Direct F1, F12
transaction REGN Common Stock Sale -$371K -379 -0.05% $978.18 786K May 16, 2024 Direct F1, F13
holding REGN Common Stock 5.9K May 16, 2024 By 401(k) Plan
holding REGN Common Stock 180K May 16, 2024 By Trust for Chldn. F14
holding REGN Common Stock 158K May 16, 2024 by 2022 GRAT II
holding REGN Common Stock 18.1K May 16, 2024 by Children
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.
F2 Represents volume-weighted average price of sales of 907 shares of Company stock on May 16, 2024 at prices ranging from $967.13 to $967.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 3,213 shares of Company stock on May 16, 2024 at prices ranging from $968.04 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 9,501 shares of Company stock on May 16, 2024 at prices ranging from $969.03 to $969.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 4,669 shares of Company stock on May 16, 2024 at prices ranging from $970.00 to $970.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 4,922 shares of Company stock on May 16, 2024 at prices ranging from $971.05 to $971.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 790 shares of Company stock on May 16, 2024 at prices ranging from $972.00 to $972.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 2,653 shares of Company stock on May 16, 2024 at prices ranging from $973.20 to $973.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 7,611 shares of Company stock on May 16, 2024 at prices ranging from $974.00 to $974.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 9,242 shares of Company stock on May 16, 2024 at prices ranging from $975.00 to $975.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 4,886 shares of Company stock on May 16, 2024 at prices ranging from $976.00 to $976.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 1,227 shares of Company stock on May 16, 2024 at prices ranging from $977.02 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F13 Represents volume-weighted average price of sales of 379 shares of Company stock on May 16, 2024 at prices ranging from $978.07 to $978.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F14 As investment trustee of trusts for the benefit of the reporting person's children.